EyePoint Pharmaceuticals, Inc. Intellectual Property Contracts & Agreements
4 Contracts & Agreements
- License Agreements (4 contracts)
- Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Betta Pharmaceuticals, Co., Ltd (Filed With SEC on August 5, 2022)
- Amendment #1 to Exclusive License Agreement, dated May 2, 2022, by and between EyePoint Pharmaceuticals, Inc. and Equinox Sciences, LLC (Filed With SEC on August 5, 2022)
- Exclusive License Agreement, dated February 3, 2020, between EyePoint Pharmaceuticals, Inc. and Equinox Science, LLC (Filed With SEC on March 16, 2020)
- SECOND AMENDMENT TO AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on September 25, 2009)
